Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-05

Clinical Trial Update: Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating phenylephrine tumescence for hemostasis during burn injury surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenylephrine (phenylephrine)

Snippet

Sponsor: University of Manitoba | Conditions: Blood Loss, Surgical | Phase 1 | Status: RECRUITING